Literature DB >> 20046330

Hospitalization of children with acute immune thrombocytopenic purpura - is it necessary?

J Berman1, Nl Young, M Carcao, V Blanchette, M Ipp.   

Abstract

OBJECTIVE: To identify a target group of children with acute immune thrombocytopenic purpura (ITP) that may not require hospitalization for management.
METHODS: A retrospective chart review was conducted of all children admitted over a two-year period to a tertiary care paediatric hospital with the diagnosis of acute ITP. Patients were classified according to typical and atypical presentations. Typical patients were defined as those aged between one and 10 years, with no hepatomegaly or significant splenomegaly and who had typical laboratory features for ITP. Patients who did not meet these criteria were categorized as atypical. Outcome measures included length of stay (LOS) in hospital; frequency of bone marrow aspiration (BMA); type of treatment; incidence of intracranial hemorrhage (ICH) or severe bleeding; and admission and discharge platelet counts.
RESULTS: There were 74 patients hospitalized for a mean of 3.6 days. No patients suffered an ICH or bleeding requiring transfusion. Patients with typical presentations (42) were compared with patients with atypical presentations (32) and were not significantly different for clinically important outcomes such as admission and discharge platelet counts, serious complications or type of therapy. Typical patients had significantly fewer BMAs than did atypical patients - 22 of 42 (52%) versus 25 of 32 (78%) (P=0.02), and a shorter LOS - 3.1 (+/-0.9) days versus 4.2 (+/-1.8) days (P=0.01).
CONCLUSIONS: Children presenting with ITP have a low incidence of bleeding complications and many of these patients can be managed as outpatients. A multicentre study is needed to properly delineate a low risk group suited for outpatient medical management.

Entities:  

Keywords:  Hospitalization; Immune thrombocytopenic purpura; Treatment

Year:  2002        PMID: 20046330      PMCID: PMC2795686          DOI: 10.1093/pch/7.6.386

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  17 in total

Review 1.  Idiopathic thrombocytopenic purpura in children: diagnosis and management.

Authors:  P D McClure
Journal:  Pediatrics       Date:  1975-01       Impact factor: 7.124

2.  Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.

Authors:  O B Eden; J S Lilleyman
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

3.  Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP).

Authors:  M D Carcao; A Zipursky; S Butchart; M Leaker; V S Blanchette
Journal:  Acta Paediatr Suppl       Date:  1998-06

4.  Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia?

Authors:  C Calpin; P Dick; A Poon; W Feldman
Journal:  Arch Pediatr Adolesc Med       Date:  1998-04

5.  Idiopathic thrombocytopenic purpura and intracranial hemorrhage.

Authors:  W Krivit; D Tate; J G White; L L Robison
Journal:  Pediatrics       Date:  1981-04       Impact factor: 7.124

6.  Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.

Authors:  D Medeiros; G R Buchanan
Journal:  J Pediatr       Date:  1998-09       Impact factor: 4.406

Review 7.  Autoimmune thrombocytopenic purpura.

Authors:  J B Bussel
Journal:  Hematol Oncol Clin North Am       Date:  1990-02       Impact factor: 3.722

8.  Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines.

Authors:  P H Bolton-Maggs; I Moon
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

9.  Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura.

Authors:  S J Woerner; C F Abildgaard; B N French
Journal:  Pediatrics       Date:  1981-04       Impact factor: 7.124

10.  Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial.

Authors:  G R Buchanan; C A Holtkamp
Journal:  Am J Pediatr Hematol Oncol       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.